Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dillon C Gavlock

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Scientific Reports|June 8, 2019
Modeling the Effect of the Metastatic Microenvironment on Phenotypes Conferred by Estrogen Receptor Mutations Using a Human Liver Microphysiological SystemMark T Miedel, Dillon C Gavlock, Shanhang Jia, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 8, 2026
Scaling human liver microphysiological systems: implementing a higher-throughput liver acinus microphysiological system platformDillon C Gavlock, Michael W Castiglione, Allen Wang, et al.
Cell Reports Methods|April 15, 2025
Validation of microphysiological systems for interpreting patient heterogeneity requires robust reproducibility analytics and experimental metadataMark T Miedel, Mahboubeh Varmazyad, Mengying Xia, et al.
BMC Methods|February 11, 2026
Road map for primary hepatocyte qualification in human liver organ modelsMahboubeh Varmazyad, Dillon C Gavlock, Michael W Castiglione, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision TherapyMengying Xia, Maboubeh Varmazyad, Iris Pla Palacin, et al.
Frontiers in Cell and Developmental Biology|September 26, 2024
Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapyMengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, et al.
Hepatology (Baltimore, Md.)|August 27, 2024
Human-induced pluripotent stem cell-based hepatic modeling of lipid metabolism-associated TM6SF2-E167K variantLanuza A P Faccioli, Yiyue Sun, Olamide Animasahun, et al.
Hepatology (Baltimore, Md.)|August 20, 2025
Human-induced pluripotent stem cell-based hepatic modeling of lipid metabolism-associated TM6SF2-E167K variantLanuza A P Faccioli, Yiyue Sun, Olamide Animasahun, et al.
JCI Insight|October 21, 2025
PNPLA3-I148M genetic variant rewires lipid metabolism to drive programmed cell death in human hepatocytesRodrigo M Florentino, Olamide Animasahun, Nils Haep, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Scientific Reports|June 8, 2019
Modeling the Effect of the Metastatic Microenvironment on Phenotypes Conferred by Estrogen Receptor Mutations Using a Human Liver Microphysiological SystemMark T Miedel, Dillon C Gavlock, Shanhang Jia, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 8, 2026
Scaling human liver microphysiological systems: implementing a higher-throughput liver acinus microphysiological system platformDillon C Gavlock, Michael W Castiglione, Allen Wang, et al.
Cell Reports Methods|April 15, 2025
Validation of microphysiological systems for interpreting patient heterogeneity requires robust reproducibility analytics and experimental metadataMark T Miedel, Mahboubeh Varmazyad, Mengying Xia, et al.
BMC Methods|February 11, 2026
Road map for primary hepatocyte qualification in human liver organ modelsMahboubeh Varmazyad, Dillon C Gavlock, Michael W Castiglione, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision TherapyMengying Xia, Maboubeh Varmazyad, Iris Pla Palacin, et al.
Frontiers in Cell and Developmental Biology|September 26, 2024
Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapyMengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, et al.
Hepatology (Baltimore, Md.)|August 27, 2024
Human-induced pluripotent stem cell-based hepatic modeling of lipid metabolism-associated TM6SF2-E167K variantLanuza A P Faccioli, Yiyue Sun, Olamide Animasahun, et al.
Hepatology (Baltimore, Md.)|August 20, 2025
Human-induced pluripotent stem cell-based hepatic modeling of lipid metabolism-associated TM6SF2-E167K variantLanuza A P Faccioli, Yiyue Sun, Olamide Animasahun, et al.
JCI Insight|October 21, 2025
PNPLA3-I148M genetic variant rewires lipid metabolism to drive programmed cell death in human hepatocytesRodrigo M Florentino, Olamide Animasahun, Nils Haep, et al.
Pageof 1